A
Arduino A. Mangoni
Researcher at Flinders Medical Centre
Publications - 397
Citations - 10350
Arduino A. Mangoni is an academic researcher from Flinders Medical Centre. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 42, co-authored 348 publications receiving 7835 citations. Previous affiliations of Arduino A. Mangoni include University of Cambridge & King's College London.
Papers
More filters
Journal ArticleDOI
Impact of age on QT interval and QT dispersion in healthy subjects: a regression analysis
TL;DR: After adjusting for gender, smoking status, and blood pressure, age and body mass index independently predicted QT interval in healthy subjects by contrast, age is not a predictor of QTd.
Journal ArticleDOI
Folic acid enhances endothelial function and reduces blood pressure in smokers: a randomized controlled trial
TL;DR: Folic acid enhances endothelial function and reduces blood pressure in smokers and promotes endothelial cell survival in smokers in a randomized controlled trial.
Journal ArticleDOI
Effect of Sympathectomy on Mechanical Properties of Common Carotid and Femoral Arteries
TL;DR: In the anesthetized normotensive rat, sympathetic activity exerts a tonic restraint on large-artery distensibility, pronounced in elastic vessels and even more pronounced in muscle-type vessels.
Journal ArticleDOI
Neutrophil to lymphocyte ratio and clinical outcomes in COPD: recent evidence and future perspectives.
Panagiotis Paliogiannis,Alessandro G. Fois,Salvatore Sotgia,Arduino A. Mangoni,Elisabetta Zinellu,Pietro Pirina,Silvia Negri,Ciriaco Carru,Angelo Zinellu +8 more
TL;DR: The available evidence from studies investigating the associations between the neutrophil to lymphocyte ratio, COPD exacerbations and death in this patient group is discussed.
Journal ArticleDOI
Drug Burden Index in older adults: theoretical and practical issues
TL;DR: A narrative review discusses the research and clinical applications of the Drug Burden Index, and its advantages and limitations, compared with other pharmacologically developed measures of high-risk prescribing.